ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 77 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $75,000 | -1.3% | 44,086 | +117.7% | 0.00% | – |
| Q4 2021 | $76,000 | -90.8% | 20,249 | -87.3% | 0.00% | – |
| Q3 2021 | $822,000 | +213.7% | 159,130 | +158.3% | 0.00% | – |
| Q2 2021 | $262,000 | +43.2% | 61,596 | +78.5% | 0.00% | – |
| Q1 2021 | $183,000 | -64.0% | 34,515 | -63.5% | 0.00% | – |
| Q4 2020 | $509,000 | +0.6% | 94,473 | +86.7% | 0.00% | – |
| Q2 2020 | $506,000 | +201.2% | 50,600 | +238.5% | 0.00% | – |
| Q1 2018 | $168,000 | – | 14,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $5,165,000 | 4.93% |
| Long Focus Capital Management, LLC | 4,429,491 | $9,125,000 | 1.17% |
| Endurant Capital Management LP | 2,160,890 | $4,451,000 | 1.17% |
| NEA Management Company, LLC | 17,082,611 | $35,190,000 | 1.02% |
| Matrix Capital Management Company, LP | 38,974,185 | $80,287,000 | 0.96% |
| Key Client Fiduciary Advisors, LLC | 420,447 | $866,000 | 0.68% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $185,000 | 0.20% |
| DAFNA Capital Management LLC | 351,064 | $723,000 | 0.19% |
| PFM Health Sciences, LP | 2,374,674 | $4,892,000 | 0.18% |
| Rock Springs Capital Management LP | 2,297,194 | $4,732,000 | 0.12% |